SEC EDGAR / 2026-10-29

8-K - Acurx Pharmaceuticals, Inc. (0001736243) (Filer)

Filed: 2026-10-29 AccNo: 0001104659-26-120279 Size: 197 KB Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Item 9.01: Financial Statements and Exhibits

Read original source

Source page screenshot: 8-K - Acurx Pharmaceuticals, Inc. (0001736243) (Filer) — Source page screenshot · www.sec.gov2026-11-06 UTC

Source record

Source: SEC EDGAR
Published: 2026-10-29 21:20:58 UTC
First discovered: 2026-10-30 08:45:21.356Z
Last collected: 2026-10-30 08:45:21.356Z
Author: Not provided
Topic: Other
Classification: Other stories
Evidence level: E1 · source record; conclusions unverified

Research analysis

Rule-based research guidance derived from the source record. Audience and commercial demand require validation.

Source record

Source account: Filed: 2026-10-29 AccNo: 0001104659-26-120279 Size: 197 KB Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Item 9.01: Financial Statements and Exhibits

Available context

No comparable records or structured measurements are attached.

Research status

This record has not been assigned a sufficiently supported main content category. No commercial or performance conclusion is generated.

Missing evidence

The main event, affected audience and supporting primary source need review.

Next step

Read the original and identify the decision it supports before choosing an analysis framework.